PT785938E - Pirrolocarbazoles fundidos - Google Patents
Pirrolocarbazoles fundidosInfo
- Publication number
- PT785938E PT785938E PT95938713T PT95938713T PT785938E PT 785938 E PT785938 E PT 785938E PT 95938713 T PT95938713 T PT 95938713T PT 95938713 T PT95938713 T PT 95938713T PT 785938 E PT785938 E PT 785938E
- Authority
- PT
- Portugal
- Prior art keywords
- inhibition
- disclosed
- compounds
- fused
- fused pyrrolocarbazoles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/323,755 US5475110A (en) | 1994-10-14 | 1994-10-14 | Fused Pyrrolocarbazoles |
US08/427,160 US5591855A (en) | 1994-10-14 | 1995-04-24 | Fused pyrrolocarbazoles |
US08/452,335 US5594009A (en) | 1994-10-14 | 1995-05-26 | Fused pyrrolocarbazoles |
US08/526,798 US5705511A (en) | 1994-10-14 | 1995-09-11 | Fused pyrrolocarbazoles |
Publications (1)
Publication Number | Publication Date |
---|---|
PT785938E true PT785938E (pt) | 2002-06-28 |
Family
ID=27502273
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT95938713T PT785938E (pt) | 1994-10-14 | 1995-10-03 | Pirrolocarbazoles fundidos |
PT00204170T PT1088823E (pt) | 1994-10-14 | 1995-10-03 | Material acrilico |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT00204170T PT1088823E (pt) | 1994-10-14 | 1995-10-03 | Material acrilico |
Country Status (17)
Country | Link |
---|---|
US (1) | US5705511A (pt) |
EP (2) | EP1088823B1 (pt) |
JP (1) | JP2001509775A (pt) |
AT (2) | ATE211472T1 (pt) |
AU (1) | AU705306B2 (pt) |
BR (1) | BR9509348A (pt) |
CA (1) | CA2202487C (pt) |
DE (2) | DE69524882T2 (pt) |
DK (2) | DK1088823T3 (pt) |
ES (2) | ES2235769T3 (pt) |
FI (1) | FI115911B (pt) |
HK (1) | HK1036622A1 (pt) |
MX (1) | MX9702682A (pt) |
NO (1) | NO308996B1 (pt) |
NZ (1) | NZ296244A (pt) |
PT (2) | PT785938E (pt) |
WO (1) | WO1996011933A1 (pt) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5808060A (en) * | 1995-12-11 | 1998-09-15 | Cephalon, Inc. | Fused isoindolones |
SE9603283D0 (sv) * | 1996-09-10 | 1996-09-10 | Astra Ab | New compounds |
UA61970C2 (en) * | 1997-08-15 | 2003-12-15 | Combined use of tyrosine kinase inhibitor and a chemical castration agent for treating prostate cancer | |
CA2245029A1 (en) | 1998-03-13 | 1999-09-13 | University Of British Columbia | Granulatimide compounds as g2 checkpoint inhibitors |
AU758241B2 (en) * | 1998-03-13 | 2003-03-20 | University Of British Columbia, The | Granulatimide derivatives for use in cancer treatment |
US6811992B1 (en) * | 1998-05-14 | 2004-11-02 | Ya Fang Liu | Method for identifying MLK inhibitors for the treatment of neurological conditions |
US6127401A (en) * | 1998-06-05 | 2000-10-03 | Cephalon, Inc. | Bridged indenopyrrolocarbazoles |
US6200968B1 (en) | 1998-08-06 | 2001-03-13 | Cephalon, Inc. | Particle-forming compositions containing fused pyrrolocarbazoles |
US7795246B2 (en) * | 1998-08-06 | 2010-09-14 | Cephalon, Inc. | Particle-forming compositions containing fused pyrrolocarbazoles |
CN1879617A (zh) * | 1998-08-26 | 2006-12-20 | 赛福伦公司 | 调节多谱系激酶蛋白 |
ATE361752T1 (de) * | 1998-09-25 | 2007-06-15 | Cephalon Inc | Methoden zur prophylaxe und behandlung von schäden der wahrnehmungshärchenzellen und der cochlearen neuronen |
US6841567B1 (en) * | 1999-02-12 | 2005-01-11 | Cephalon, Inc. | Cyclic substituted fused pyrrolocarbazoles and isoindolones |
US6399780B1 (en) * | 1999-08-20 | 2002-06-04 | Cephalon, Inc. | Isomeric fused pyrrolocarbazoles and isoindolones |
GB0002952D0 (en) * | 2000-02-09 | 2000-03-29 | Pharma Mar Sa | Process for producing kahalalide F compounds |
US20060276497A1 (en) | 2000-05-09 | 2006-12-07 | Cephalon, Inc. | Novel multicyclic compounds and the use thereof |
US7122679B2 (en) * | 2000-05-09 | 2006-10-17 | Cephalon, Inc. | Multicyclic compounds and the use thereof |
JP2005503102A (ja) * | 2000-08-11 | 2005-02-03 | セフアロン・インコーポレーテツド | 多重系統キナーゼタンパク質の調節および多重系統キナーゼタンパク質を調節する化合物のスクリーニング方法。 |
AU2001285205B2 (en) * | 2000-08-25 | 2007-03-01 | Cephalon, Inc. | Fused pyrrolocarbazoles against inflammation |
US6630500B2 (en) * | 2000-08-25 | 2003-10-07 | Cephalon, Inc. | Selected fused pyrrolocarbazoles |
US6677450B2 (en) | 2000-10-06 | 2004-01-13 | Bristol-Myers Squibb Company | Topoisomerase inhibitors |
US6610727B2 (en) | 2000-10-06 | 2003-08-26 | Bristol-Myers Squibb Company | Anhydro sugar derivatives of indolocarbazoles |
US6653290B2 (en) * | 2000-10-06 | 2003-11-25 | Bristol-Myers Squibb Company | Tumor proliferation inhibitors |
SK12022003A3 (sk) | 2001-03-22 | 2004-05-04 | Bristol-Myers Squibb Company | Na topoizomerázu I selektívne cytotoxické cukrové deriváty indolpyrolkarbazolov |
US7018999B2 (en) * | 2001-05-16 | 2006-03-28 | Cephalon, Inc. | Methods for the treatment and prevention of pain |
FR2826653B1 (fr) * | 2001-06-29 | 2005-10-14 | Servier Lab | Nouveaux derives de pyrido-pyrido-pyrrolo[3,2-g]pyrrolo [3,4-e]-indole et pyrido-pyrrolo[2,3-a]pyrrolo[3,4-c] carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
IL144583A0 (en) | 2001-07-26 | 2002-05-23 | Peptor Ltd | Chimeric protein kinase inhibitors |
US20050054555A1 (en) * | 2001-10-19 | 2005-03-10 | Jose Jimeno | Kahalalide compounds for use in cancer therapy |
US7482134B2 (en) * | 2002-06-05 | 2009-01-27 | Seoul National University Industry Foundation | Signals and molecular species involved in senescence |
FR2845997B1 (fr) * | 2002-10-18 | 2004-12-24 | Servier Lab | Nouveaux derives de[1,4]benzodioxino[2,3-e]isoindole substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
GB0304367D0 (en) * | 2003-02-26 | 2003-04-02 | Pharma Mar Sau | Methods for treating psoriasis |
US7507708B2 (en) * | 2003-02-26 | 2009-03-24 | Pharma Mar, S.A.U. | Antitumoral compounds |
AU2003250150A1 (en) * | 2003-07-23 | 2005-02-25 | Creabilis Therapeutics S.R.L. | Topical use of tyrosine kinase inhibitors of microbial origin to prevent and treat skin disorders characterised by excessive cell proliferation |
GB0321066D0 (en) * | 2003-09-09 | 2003-10-08 | Pharma Mar Sau | New antitumoral compounds |
US7241779B2 (en) * | 2003-12-23 | 2007-07-10 | Cephalon, Inc. | Fused pyrrolocarbazoles |
US7169802B2 (en) * | 2003-12-23 | 2007-01-30 | Cephalon, Inc. | Fused pyrrolocarbazoles |
MX2007001155A (es) * | 2004-07-29 | 2007-08-14 | Creabilis Therapeutics Spa | Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1. |
US20060058250A1 (en) * | 2004-09-10 | 2006-03-16 | Cephalon, Inc. | Methods of treating proliferative skin diseases using carbazole derivatives |
KR100734429B1 (ko) * | 2004-12-06 | 2007-07-03 | 재단법인서울대학교산학협력재단 | 노화에 관여하는 신호 및 분자종 |
US20060134175A1 (en) * | 2004-12-22 | 2006-06-22 | Stephen Bartels | Drug eluting pharmaceutical delivery system for treatment of ocular disease and method of use |
US20060134176A1 (en) * | 2004-12-22 | 2006-06-22 | Bausch & Lomb Incorporated | Pharmaceutical delivery system and method of use |
US20060134174A1 (en) * | 2004-12-22 | 2006-06-22 | Bausch & Lomb Incorporated | Pharmaceutical delivery system and method of use |
US20060293378A1 (en) * | 2005-06-28 | 2006-12-28 | Mcintire Gregory | Method of lowering intraocular pressure |
JP2009511524A (ja) | 2005-10-11 | 2009-03-19 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | ケモカイン発現のegfr依存調節ならびに腫瘍とその副作用の治療及び診断に与えるケモカイン発現調節の影響 |
US20070249590A1 (en) * | 2005-10-28 | 2007-10-25 | Wilson Lawrence J | Substituted indolo[2,3-a]pyrrolo[3,4-c]carbazole compounds useful in treating kinase disorders |
US20080021013A1 (en) * | 2006-07-21 | 2008-01-24 | Cephalon, Inc. | JAK inhibitors for treatment of myeloproliferative disorders |
KR100831367B1 (ko) | 2007-02-16 | 2008-05-22 | 재단법인서울대학교산학협력재단 | 아데닐일 시클라아제의 억제제를 노화 세포에 처리하는 단계를 포함하는 세포의 노화 조절방법 및 아데닐일 시클라아제의 억제제를 포함하는 세포 노화 조절용 조성물 |
KR20100099128A (ko) * | 2007-10-19 | 2010-09-10 | 파르마 마르 에스.에이. | 개선된 항암치료 |
WO2009067221A2 (en) * | 2007-11-20 | 2009-05-28 | Cephalon, Inc. | Microemulsion containing indolocarbazole compound and dosage forms containing the same |
WO2009073620A2 (en) * | 2007-11-30 | 2009-06-11 | Newlink Genetics | Ido inhibitors |
EP2367829B1 (en) * | 2008-11-19 | 2013-01-02 | Cephalon, Inc. | Novel forms of an indazolo [5,4-a] pyrrolo [3,4-c] carbazole compound |
EP2192121A1 (en) * | 2008-11-27 | 2010-06-02 | Cephalon France | Regioselective reduction of fused pyrrolocarbazoles-5,7-diones |
CN102482279B (zh) * | 2009-03-30 | 2015-08-12 | 德山新勒克斯 | 有机电子装置及其化合物与终端机 |
KR101182438B1 (ko) * | 2009-08-14 | 2012-09-12 | 삼성디스플레이 주식회사 | 유기 발광 소자 |
AU2013362134B2 (en) | 2012-12-21 | 2018-07-05 | Sykehuset Sorlandet Hf | EGFR targeted therapy of neurological disorders and pain |
US11173145B2 (en) | 2017-01-17 | 2021-11-16 | Board Of Regents, The University Of Texas System | Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase |
DE102017117328A1 (de) * | 2017-07-31 | 2019-01-31 | Mitsubishi Polyester Film Gmbh | Peelfähige Polyesterfolie, Verfahren zu ihrer Herstellung und ihre Verwendung |
WO2020018670A1 (en) | 2018-07-17 | 2020-01-23 | Board Of Regents, The University Of Texas System | Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4552842A (en) * | 1983-01-28 | 1985-11-12 | Bristol-Myers Company | Process for producing rebeccamycin |
DE3752123T2 (de) * | 1987-03-09 | 1998-05-14 | Kyowa Hakko Kogyo Kk | Derivate des physiologisch aktiven mittels k-252 |
DE3835842A1 (de) * | 1988-10-21 | 1990-04-26 | Goedecke Ag | Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel |
NZ227850A (en) * | 1988-02-10 | 1991-11-26 | Hoffmann La Roche | Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders |
DE3833008A1 (de) * | 1988-09-29 | 1990-04-05 | Goedecke Ag | Pyrrolocarbozol-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel |
MC2096A1 (fr) * | 1989-02-23 | 1991-02-15 | Hoffmann La Roche | Pyrroles substitues |
US5185260A (en) * | 1991-08-29 | 1993-02-09 | The United States Of America As Represented By The United States Department Of Energy | Method for distinguishing normal and transformed cells using G1 kinase inhibitors |
NZ245203A (en) * | 1991-11-29 | 1997-07-27 | Banyu Pharma Co Ltd | 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates |
US6271242B1 (en) * | 1992-02-10 | 2001-08-07 | Bristol-Myers Squibb Co. | Method for treating cancer using a tyrosine protein kinase inhibitor |
US5405864A (en) * | 1993-10-15 | 1995-04-11 | Syntex (U.S.A.) Inc. | Chemotherapeutic maleimides |
DE4337521A1 (de) * | 1993-11-03 | 1995-05-04 | Teves Gmbh Alfred | Verfahren zur Funktionsprüfung eines hydraulischen Aggregats |
-
1995
- 1995-09-11 US US08/526,798 patent/US5705511A/en not_active Expired - Lifetime
- 1995-10-03 AT AT95938713T patent/ATE211472T1/de active
- 1995-10-03 AT AT00204170T patent/ATE286055T1/de active
- 1995-10-03 WO PCT/US1995/012761 patent/WO1996011933A1/en active IP Right Grant
- 1995-10-03 CA CA002202487A patent/CA2202487C/en not_active Expired - Lifetime
- 1995-10-03 DK DK00204170T patent/DK1088823T3/da active
- 1995-10-03 EP EP00204170A patent/EP1088823B1/en not_active Expired - Lifetime
- 1995-10-03 DK DK95938713T patent/DK0785938T3/da active
- 1995-10-03 NZ NZ296244A patent/NZ296244A/en not_active IP Right Cessation
- 1995-10-03 ES ES00204170T patent/ES2235769T3/es not_active Expired - Lifetime
- 1995-10-03 ES ES95938713T patent/ES2170812T3/es not_active Expired - Lifetime
- 1995-10-03 DE DE69524882T patent/DE69524882T2/de not_active Expired - Lifetime
- 1995-10-03 MX MX9702682A patent/MX9702682A/es unknown
- 1995-10-03 EP EP95938713A patent/EP0785938B1/en not_active Expired - Lifetime
- 1995-10-03 AU AU39986/95A patent/AU705306B2/en not_active Expired
- 1995-10-03 PT PT95938713T patent/PT785938E/pt unknown
- 1995-10-03 PT PT00204170T patent/PT1088823E/pt unknown
- 1995-10-03 BR BR9509348A patent/BR9509348A/pt not_active IP Right Cessation
- 1995-10-03 DE DE69533899T patent/DE69533899T2/de not_active Expired - Lifetime
- 1995-10-03 JP JP51328996A patent/JP2001509775A/ja not_active Ceased
-
1997
- 1997-04-09 FI FI971479A patent/FI115911B/fi not_active IP Right Cessation
- 1997-04-11 NO NO971677A patent/NO308996B1/no not_active IP Right Cessation
-
2001
- 2001-10-04 HK HK01106989A patent/HK1036622A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0785938A1 (en) | 1997-07-30 |
EP1088823B1 (en) | 2004-12-29 |
WO1996011933A1 (en) | 1996-04-25 |
NO971677L (no) | 1997-06-11 |
CA2202487C (en) | 2008-06-17 |
EP0785938B1 (en) | 2002-01-02 |
PT1088823E (pt) | 2005-03-31 |
ATE211472T1 (de) | 2002-01-15 |
DE69524882D1 (de) | 2002-02-07 |
DE69533899T2 (de) | 2005-12-08 |
EP1088823A1 (en) | 2001-04-04 |
AU705306B2 (en) | 1999-05-20 |
FI971479A0 (fi) | 1997-04-09 |
FI115911B (fi) | 2005-08-15 |
NZ296244A (en) | 1998-11-25 |
CA2202487A1 (en) | 1996-04-25 |
DE69533899D1 (de) | 2005-02-03 |
US5705511A (en) | 1998-01-06 |
MX9702682A (es) | 1998-02-28 |
ATE286055T1 (de) | 2005-01-15 |
JP2001509775A (ja) | 2001-07-24 |
FI971479A (fi) | 1997-06-11 |
NO308996B1 (no) | 2000-11-27 |
DE69524882T2 (de) | 2002-09-12 |
ES2170812T3 (es) | 2002-08-16 |
NO971677D0 (no) | 1997-04-11 |
BR9509348A (pt) | 1997-11-04 |
DK0785938T3 (da) | 2002-04-22 |
HK1036622A1 (en) | 2002-01-11 |
AU3998695A (en) | 1996-05-06 |
DK1088823T3 (da) | 2005-04-25 |
ES2235769T3 (es) | 2005-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9509348A (pt) | Pirrolocarbazóis fundidos | |
ATE172201T1 (de) | Morphinan-derivate und medizinische verwendung | |
ES2080359T3 (es) | Derivados de guanidina, su produccion e insecticidas. | |
ATE129498T1 (de) | Kondensierte heterozyklische verbindungen, ihre herstellung und verwendung. | |
ATE13178T1 (de) | 2-oxoazetidin-derivate, ihre herstellung und verwendung. | |
DK0392560T3 (da) | Diaminoethylenforbindelser | |
ES8706638A1 (es) | Un procedimiento para la preparacion de nuevos compuestos de sulfonilurea | |
ATE224361T1 (de) | Pestizide | |
ATE80613T1 (de) | Verwendung von spergualinderivaten zur herstellung von arzneimitteln mit immunodepressiver wirkung. | |
DE59404557D1 (de) | Hetero-tricyclisch-substituierte Phenyl-cyclohexan-carbonsäurederivate | |
ES8704890A1 (es) | Un procedimiento para la preparacion de nuevas sulfonilureas. | |
EP0205323A3 (en) | Cyanoheterocyclic sulfonylureas | |
BR8108862A (pt) | Hidroximidato e tiol-hidroximidatos heterobiciclicos e seus derivados ester -carbamato com atividade biologica | |
ES2039270T3 (es) | Derivados de gamma-l-glutamil-4-nitroanilida y procedimiento para determinar actividad de gamma-gtp utilizandolos. |